William Wood
Stock Analyst at B. Riley Securities
(3.30)
# 2,455
Out of 4,983 analysts
61
Total ratings
45.3%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by William Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Reiterated: Buy | $11 → $8 | $3.20 | +150.00% | 11 | Sep 11, 2026 | |
| MBOT Microbot Medical | Initiated Coverage: Buy | $4 | $1.42 | +181.69% | 1 | Sep 11, 2026 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $85 | $29.36 | +189.51% | 2 | Sep 9, 2026 | |
| IMUX Immunic | Reiterated: Buy | $27 | $10.35 | +160.87% | 11 | Sep 2, 2026 | |
| TGTX TG Therapeutics | Reiterated: Buy | $86 | $56.47 | +52.29% | 3 | Sep 2, 2026 | |
| IBIO iBio, Inc. | Initiated Coverage: Buy | $6 | $1.25 | +380.00% | 1 | Aug 31, 2026 | |
| ACOG Alpha Cognition | Initiated Coverage: Buy | $21 | $8.86 | +137.02% | 1 | Aug 20, 2026 | |
| AGMB AgomAb Therapeutics NV | Initiated Coverage: Buy | $34 | $12.08 | +181.46% | 1 | Jul 23, 2026 | |
| TRVI Trevi Therapeutics | Reiterated: Buy | $31 | $15.21 | +103.81% | 1 | Jul 17, 2026 | |
| EQ Equillium | Reiterated: Buy | $6 | $1.89 | +217.46% | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.70 | +311.76% | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $5.53 | +26.58% | 3 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.24 | +301.23% | 1 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $560 → $670 | $534.40 | +25.37% | 3 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $1.32 | +278.79% | 1 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.06 | +183.02% | 1 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $2.39 | n/a | 7 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $13.74 | n/a | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $3.22 | n/a | 4 | May 2, 2024 |
LifeMD
Sep 11, 2026
Reiterated: Buy
Price Target: $11 → $8
Current: $3.20
Upside: +150.00%
Microbot Medical
Sep 11, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $1.42
Upside: +181.69%
Viking Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $85
Current: $29.36
Upside: +189.51%
Immunic
Sep 2, 2026
Reiterated: Buy
Price Target: $27
Current: $10.35
Upside: +160.87%
TG Therapeutics
Sep 2, 2026
Reiterated: Buy
Price Target: $86
Current: $56.47
Upside: +52.29%
iBio, Inc.
Aug 31, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $1.25
Upside: +380.00%
Alpha Cognition
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $8.86
Upside: +137.02%
AgomAb Therapeutics NV
Jul 23, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $12.08
Upside: +181.46%
Trevi Therapeutics
Jul 17, 2026
Reiterated: Buy
Price Target: $31
Current: $15.21
Upside: +103.81%
Equillium
Jun 2, 2026
Reiterated: Buy
Price Target: $6
Current: $1.89
Upside: +217.46%
Jun 2, 2026
Reiterated: Buy
Price Target: $7
Current: $1.70
Upside: +311.76%
May 15, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $5.53
Upside: +26.58%
Mar 6, 2026
Reiterated: Buy
Price Target: $13
Current: $3.24
Upside: +301.23%
Dec 11, 2025
Reiterated: Buy
Price Target: $560 → $670
Current: $534.40
Upside: +25.37%
Dec 8, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $1.32
Upside: +278.79%
Nov 21, 2025
Reiterated: Buy
Price Target: $3
Current: $1.06
Upside: +183.02%
Feb 11, 2025
Reiterated: Buy
Price Target: $50
Current: $2.39
Upside: n/a
May 8, 2024
Reiterated: Buy
Price Target: $10
Current: $13.74
Upside: n/a
May 2, 2024
Reiterated: Buy
Price Target: $4
Current: $3.22
Upside: n/a